All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| HAE / Haemonetics Corporation
|
|
|
|
|
|
|
|
| MDT / Medtronic plc
|
|
|
|
|
|
|
|
| RPHM / Reneo Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ODT / Odonate Therapeutics Inc
|
|
|
|
|
|
|
|
| ZBH / Zimmer Biomet Holdings, Inc.
|
|
|
|
|
|
|
|
| LHCG / LHC Group Inc
|
|
|
|
|
|
|
|
| CANO / Cano Health, Inc.
|
|
|
|
|
|
|
|
| AUPH / Aurinia Pharmaceuticals Inc. Call
|
|
|
|
|
|
|
|
| CARA / Cara Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ASMB / Assembly Biosciences, Inc.
|
|
|
|
|
|
|
|
| US0153511094 / Alexion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ATIP / ATI Physical Therapy, Inc.
|
|
|
|
|
|
|
|
| QSI / Quantum-Si incorporated
|
|
|
|
|
|
|
|
| XFOR / X4 Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ADMA / ADMA Biologics, Inc.
|
|
|
|
|
|
|
|
| ORGO / Organogenesis Holdings Inc.
|
|
|
|
|
|
|
|
| BEAM / Beam Therapeutics Inc.
|
|
|
|
|
|
|
|
| VRTX / Vertex Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
| AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
| EVH / Evolent Health, Inc.
|
|
|
|
|
|
|
|
| INOV / Innovator ETFs Trust - Innovator International Developed Power Buffer ETF - November
|
|
|
|
|
|
|
|
| APTO / Aptose Biosciences Inc.
|
|
|
|
|
|
|
|
| AKU / Akumin Inc
|
|
|
|
|
|
|
|
| MTCR / Metacrine Inc
|
|
|
|
|
|
|
|
| ONCR / Oncorus, Inc.
|
|
|
|
|
|
|
|
| SLDB / Solid Biosciences Inc.
|
|
|
|
|
|
|
|
| ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
| RCM / R1 RCM Inc.
|
|
|
|
|
|
|
|
| BAX / Baxter International Inc.
|
|
|
|
|
|
|
|
| MORF / Morphic Holding, Inc.
|
|
|
|
|
|
|
|
| CNVY / Convey Health Solutions Holdings Inc
|
|
|
|
|
|
|
|
| OSCR / Oscar Health, Inc.
|
|
|
|
|
|
|
|
| EHC / Encompass Health Corporation
|
|
|
|
|
|
|
|
| IRTC / iRhythm Technologies, Inc.
|
|
|
|
|
|
|
|
| CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| XCUR / Exicure, Inc.
|
|
|
|
|
|
|
|
| IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| KALV / KalVista Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| SIOX / Sio Gene Therapies Inc.
|
|
|
|
|
|
|
|
| PRQR / ProQR Therapeutics N.V.
|
|
|
|
|
|
|
|
| CLOV / Clover Health Investments, Corp.
|
|
|
|
|
|
|
|
| ALBO / Albireo Pharma Inc
|
|
|
|
|
|
|
|
| ALBO / Albireo Pharma Inc Call
|
|
|
|
|
|
|
|
| CUE / Cue Biopharma, Inc.
|
|
|
|
|
|
|
|
| NUVB / Nuvation Bio Inc.
|
|
|
|
|
|
|
|
| UNH / UnitedHealth Group Incorporated
|
|
|
|
|
|
|
|
| ALDX / Aldeyra Therapeutics, Inc.
|
|
|
|
|
|
|
|
| OPCH / Option Care Health, Inc.
|
|
|
|
|
|
|
|
| MGTX / MeiraGTx Holdings plc
|
|
|
|
|
|
|
|
| KZR / Kezar Life Sciences, Inc.
|
|
|
|
|
|
|
|
| GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| PRTA / Prothena Corporation plc
|
|
|
|
|
|
|
|
